- Home
- IOVA vs AMPH Comparison
IOVA vs AMPH Comparison
Compare IOVA & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- AMPH
- Stock Information
- Founded
- IOVA 2007
- AMPH 1996
- Country
- IOVA United States
- AMPH United States
- Employees
- IOVA N/A
- AMPH N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- IOVA Health Care
- AMPH Health Care
- Exchange
- IOVA Nasdaq
- AMPH Nasdaq
- Market Cap
- IOVA N/A
- AMPH 1.3B
- IPO Year
- IOVA N/A
- AMPH 2014
- Fundamental
- Price
- IOVA $3.28
- AMPH $28.29
- Analyst Decision
- IOVA Strong Buy
- AMPH Hold
- Analyst Count
- IOVA 8
- AMPH 3
- Target Price
- IOVA $20.25
- AMPH $43.50
- AVG Volume (30 Days)
- IOVA 8.3M
- AMPH 569.1K
- Earning Date
- IOVA 05-08-2025
- AMPH 05-07-2025
- Dividend Yield
- IOVA N/A
- AMPH N/A
- EPS Growth
- IOVA N/A
- AMPH 17.69
- EPS
- IOVA N/A
- AMPH 3.06
- Revenue
- IOVA $164,070,000.00
- AMPH $731,967,000.00
- Revenue This Year
- IOVA $181.92
- AMPH $2.60
- Revenue Next Year
- IOVA $66.10
- AMPH $9.42
- P/E Ratio
- IOVA N/A
- AMPH $9.25
- Revenue Growth
- IOVA 13698.99
- AMPH 13.59
- 52 Week Low
- IOVA $3.19
- AMPH $25.89
- 52 Week High
- IOVA $14.23
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- IOVA 28.74
- AMPH 43.50
- Support Level
- IOVA $3.19
- AMPH $28.01
- Resistance Level
- IOVA $3.66
- AMPH $29.18
- Average True Range (ATR)
- IOVA 0.20
- AMPH 0.79
- MACD
- IOVA 0.05
- AMPH 0.35
- Stochastic Oscillator
- IOVA 11.64
- AMPH 72.95
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.